Martin Blüggel
Board & Investor at mo:re · Dortmund, Germany
Invests in AIAI is one of the sectors on Martin Blüggel's investor profile, next to Healthcare & Biotech and Biotech & Pharma, at seed and Series A. No deals are on record yet, so this page lists the startup credits a company at these stages can claim.
Email InvestorCredits to line up before a seed round
Martin Blüggel backs companies at seed and Series A. A few of the larger credit programs on AI Perks for teams at that point:
Investment focus
- Backs startups in
- Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma
- Rounds
- Seed, Series A
- Profile
- Angel investor
- Deals on record
- None yet
- Based in
- Dortmund, Germany

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Tobias SchimmelpfennigInvestment Director at IBB Ventures
- Pawel SchapiroInvestment Manager at KfW Capital
- Markus LehmannCEO at IBB Ventures
- Benedikt KronbergerPartner at Matterwave Ventures
- Florian ReichertPartner & Managing Director at Picus Capital
- Johannes FischerPartner at Wellington Partners
- Johanna LiebnerVenture investor in Germany
- Sebastian SchaeferPartner at Picus Capital
Questions founders ask
- Does Martin Blüggel invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Martin Blüggel's investor profile, together with Healthcare & Biotech and Biotech & Pharma. The stages on record are seed and Series A.
- What credits can a startup claim before pitching Martin Blüggel?
- For a company raising a seed round, AI Perks lists credits such as Gemini (up to $350,000), Replit (up to $25,000), Oracle (up to $10,000) and IBM Cloud (up to $120,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal